APA (7th ed.) Citation

T, S., L, S., O, J., F, J., P, S., SB, R., & P, S. (2025). Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients. Frontiers in oncology, 15, 1472714. https://doi.org/10.3389/fonc.2025.1472714

Chicago Style (17th ed.) Citation

T, Seery, Sender L, Jafari O, Jones F, Spilman P, Reddy SB, and Soon-Shiong P. "Case Report: PD-L1-targeted High-affinity Natural Killer Cells and IL-15 Superagonist N-803-based Therapy Extend Overall Survival of Advanced Metastatic Pancreatic Cancer Patients." Frontiers in Oncology 15 (2025): 1472714. https://doi.org/10.3389/fonc.2025.1472714.

MLA (9th ed.) Citation

T, Seery, et al. "Case Report: PD-L1-targeted High-affinity Natural Killer Cells and IL-15 Superagonist N-803-based Therapy Extend Overall Survival of Advanced Metastatic Pancreatic Cancer Patients." Frontiers in Oncology, vol. 15, 2025, p. 1472714, https://doi.org/10.3389/fonc.2025.1472714.